Irisin
9
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
The Effect of Exercise on Serum Irisin Levels and Clinical Parameters in Patients With Axial Spondyloarthritis.
The Acute Effect of Different Resistance Exercise Loads on Irisin and Brain-derived Neurotrophic Factor in Blood Serum and Plasma
Jackfruit Effects on Adipokines and Cognition in Boxers
Temporal Dynamics of Irisin
Effects of Different Types of Exercise on Irisin and Cognitive Performance (Exercise-Irisin)
Irisin And Diabetic Nephropathy
Effect of an Exercise on Serum Uncoupling Protein-1 Level and the Role of Uncoupling Protein-1-3826 A/G Polymorphism
Cord Blood Nesfatin-1 and Irisin in the Intrauterine Growth Restricted Fetuses
The Relation Between Plasma Irisin Level and Endothelial Dysfunction in Type 2 Diabetes